Public map story

Eve Hewson · Cosmic Mosaic

A moment shaping the map: News pulse 2026-08-26 · Reuters: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. A perspective from London.

party · Porto, PT · 0 likes · 1 replies